Tealwood Asset Management Inc Corcept Therapeutics Inc Transaction History

Tealwood Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 06, 2019	SELL	$9.78 - $12.76 $1.51 Million - $1.97 Million	-154,615 Closed	0 $0
Q1 2019 Apr 15, 2019	BUY	$10.03 - $15.71 $522,252 - $818,003	52,069 Added 50.78%	154,615 $1.82 Million
Q4 2018 Jan 15, 2019	SELL	$11.29 - $17.19 $371,576 - $565,757	-32,912 Reduced 24.3%	102,546 $1.37 Million
Q3 2018 Oct 16, 2018	SELL	$12.27 - $15.65 $9,693 - $12,363	-790 Reduced 0.58%	135,458 $1.9 Million
Q2 2018 Jul 25, 2018	BUY	$15.3 - $19.69 $2.08 Million - $2.68 Million	136,248 New	136,248 $2.14 Million

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.39B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Tealwood Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Tealwood Asset Management Inc with notifications on news.